Dr. John Cienki, MD
Claim this profileJackson Memorial Hospital
Studies Coronavirus
Studies COVID-19
3 reported clinical trials
6 drugs studied
Area of expertise
1Coronavirus
SARS-CoV-2
PCR
collection
2COVID-19
SARS-CoV-2
Affiliated Hospitals
Jackson Memorial Hospital
More about John Cienki, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments John Cienki, MD has experience with
- Montelukast
- Placebo
- Ivermectin
- Fluvoxamine
- Fluticasone
- Metformin
Breakdown of trials John Cienki, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Cienki, MD specialize in?
John Cienki, MD focuses on Coronavirus and COVID-19. In particular, much of their work with Coronavirus has involved SARS-CoV-2 patients, or patients who are PCR.
Is John Cienki, MD currently recruiting for clinical trials?
No, John Cienki, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that John Cienki, MD has studied deeply?
Yes, John Cienki, MD has studied treatments such as Montelukast, Placebo, Ivermectin.
What is the best way to schedule an appointment with John Cienki, MD?
Apply for one of the trials that John Cienki, MD is conducting.
What is the office address of John Cienki, MD?
The office of John Cienki, MD is located at: Jackson Memorial Hospital, Miami, Florida 33136 United States. This is the address for their practice at the Jackson Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.